Ofira Zloto, Alon Weisman, Inbal Avisar, Tal Serlin, Lihi Bar-lev, Ayelet Priel, Daphna Landau Prat, Nira Granot, Iris Weisman & Guy Ben Simon. (2022) Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study. Graefe's Archive for Clinical and Experimental Ophthalmology 260:5, pages 1707-1712.
Crossref
Sindhu Ramesh, Kruthi Gopal, Jack Deruiter, Payton Lowery, Manoj Govindarajulu, Suhrud Pathak, Rishi Nadar, Dinesh Chandra Agrawal & Muralikrishnan Dhanasekaran. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
155
172
.
Dylan Bowen, Sindhu Ramesh, Jack Deruiter, Manoj Govindarajulu, Payton Lowery, Timothy Moore, Dinesh Chandra Agrawal & Muralikrishnan Dhanasekaran. 2022. Cannabis/Marijuana for Healthcare. Cannabis/Marijuana for Healthcare
35
52
.
Wilfrid Beneche, Lisa Cain & Andrew Moreo. (2023) A High Wire Act: Balancing Guest, Employee, and Organizational Perspectives concerning Marijuana Use in the Hospitality Industry. Journal of Hospitality & Tourism Cases 9:4, pages 6-11.
Crossref
Susan J. Thanabalasingam, Brandan Ranjith, Robyn Jackson & Don Thiwanka Wijeratne. (2021) Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis. Therapeutic Advances in Neurological Disorders 14, pages 175628642110185.
Crossref
Genís Oña & José Carlos Bouso. (2020) Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology. Current Medicinal Chemistry 28:1, pages 53-68.
Crossref
Stefan Dhein. (2020) Different Effects of Cannabis Abuse on Adolescent and Adult Brain. Pharmacology 105:11-12, pages 609-617.
Crossref
Tyler E. Gaston, Jerzy P. Szaflarski, Allen C. Bowling, Ying Liu, Tristan Seawalt, Maureen A. Leehey, E. Lee Nelson, Sharad Rajpal, Alan T. Villavicencio, Andrew Bauer & Sigita Burneikiene. 2020. Cannabis in Medicine. Cannabis in Medicine
231
312
.
Adeyinka Charles AdejumoRyan FlanaganBraden KuoKyle Staller. (2019) Relationship Between Recreational Marijuana Use and Bowel Function in a Nationwide Cohort Study. American Journal of Gastroenterology 114:12, pages 1894-1903.
Crossref
Arum KimChristopher N. KaufmannRoxanne KoZujun LiBenjamin H. Han. (2019) Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State. Journal of Palliative Medicine 22:10, pages 1196-1201.
Crossref
José Alexandre S. Crippa, Jaime E. C. Hallak, Antônio W. Zuardi, Francisco S. Guimarães, Vitor Tumas & Rafael G. dos Santos. (2019) Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 121-133.
Crossref
Nancy Maurya & Bharath Kumar Velmurugan. (2018) Therapeutic applications of cannabinoids. Chemico-Biological Interactions 293, pages 77-88.
Crossref
Emilio Perucca. (2017) Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?. Journal of Epilepsy Research 7:2, pages 61-76.
Crossref
James A. Cranford, J. Todd Arnedt, Deirdre A. Conroy, Kipling M. Bohnert, Carrie Bourque, Frederic C. Blow & Mark Ilgen. (2017) Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain. Drug and Alcohol Dependence 180, pages 227-233.
Crossref
Samir K. Ballas. (2017) The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises. Cannabis and Cannabinoid Research 2:1, pages 197-201.
Crossref
Hélio A. G. Teive, Francisco M.B. Germiniani, Pedro A. Kowacs & Renato P. Munhoz. (2016) Charcot, Mitchell and Lees: neurology free thinkers and their experiences of psychoactive drugs. Arquivos de Neuro-Psiquiatria 74:12, pages 1035-1038.
Crossref
Pichet Termsarasab, Thananan Thammongkolchai & Steven J. Frucht. (2016) Medical treatment of dystonia. Journal of Clinical Movement Disorders 3:1.
Crossref
David Z. Rose. (2016) What a downer: The dark side of cannabis. Journal of the Neurological Sciences 364, pages 189-190.
Crossref
Jonathan Rabner, Sarah Gottlieb, Lori Lazdowsky & Alyssa LeBel. (2016) Psychosis following traumatic brain injury and cannabis use in late adolescence. The American Journal on Addictions 25:2, pages 91-93.
Crossref
Cecilia Zavala-Tecuapetla & Luisa Rocha. 2016. Antiepileptic Drug Discovery. Antiepileptic Drug Discovery
83
96
.
Jane Sachs, Erin McGlade & Deborah Yurgelun-Todd. (2015) Safety and Toxicology of Cannabinoids. Neurotherapeutics 12:4, pages 735-746.
Crossref
Barbara S. Koppel. (2015) Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics. Neurotherapeutics 12:4, pages 788-792.
Crossref
Magdalena Taschwer & Martin G. Schmid. (2015) Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability. Forensic Science International 254, pages 167-171.
Crossref
Briony Catlow & Juan Sanchez-Ramos. (2015) Cannabinoids for the Treatment of Movement Disorders. Current Treatment Options in Neurology 17:9.
Crossref
Juan Sanchez‐Ramos. (2015) The entourage effect of the phytocannabinoids. Annals of Neurology 77:6, pages 1083-1083.
Crossref
Clifford B. Saper. (2015) Reply to Letter. Annals of Neurology 77:6, pages 1083-1084.
Crossref
Donald E. Greydanus, Gabriel Kaplan, Louis E. BaxterSrSr, Dilip R. Patel & Cynthia L. Feucht. (2015) Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?. Disease-a-Month 61:4, pages 118-175.
Crossref
Melvyn Weibin Zhang & Roger C. M. Ho. (2015) The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. Journal of Addiction 2015, pages 1-6.
Crossref
István Katona. 2015. Endocannabinoids. Endocannabinoids
285
316
.